Nuveen’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158M Buy
326,756
+46,681
+17% +$12.4M 0.04% 323
2026
Q1
$30.7M Buy
280,075
+17,379
+7% +$2.48M 0.01% 896
2025
Q4
$43.7M Sell
262,696
-6,177
-2% -$1.03M 0.01% 710
2025
Q3
$52.6M Sell
268,873
-3,005
-1% -$494K 0.01% 595
2025
Q2
$24.6M Buy
271,878
+4,370
+2% +$345K 0.01% 968
2025
Q1
$16M Sell
267,508
-210,104
-44% -$19.4M ﹤0.01% 1267
2024
Q4
$63.3M Buy
477,612
+429,903
+901% +$40.3M 0.02% 551
2024
Q3
$2.5M Buy
47,709
+15,102
+46% +$709K ﹤0.01% 2311
2024
Q2
$1.97M Buy
32,607
+107
+0.3% +$7.42K ﹤0.01% 2406
2024
Q1
$2.41M Buy
+32,500
New +$2.41M ﹤0.01% 2311

Other funds holding ALAB

Nuveen's ALAB Position: Q2 2026 in Review

Nuveen increased its Astera Labs (ALAB) stake by 17% in Q2 2026, buying an estimated $12.4M and bringing the position to 326,756 shares worth $158M. The position accounts for 0.04% of the portfolio, ranked #323.

Nuveen first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Nuveen held 326,756 shares of Astera Labs worth $158M as of Q2 2026.
  • Nuveen bought 46,681 Astera Labs shares in Q2 2026, an estimated $12.4M.
  • Astera Labs made up 0.04% of Nuveen's portfolio in Q2 2026, its #323 holding.
  • Nuveen first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.